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Abstract
Background and Aims: Deoxynivalenol (DON) is a Fusarium derived mycotoxin, often occurring on cereals used for human
and animal nutrition. The intestine, as prominent barrier for nutritional toxins, has to handle the mycotoxin from the mucosa
protected luminal side (apical exposure), as well as already absorbed toxin, reaching the cells from basolateral side via the
blood stream. In the present study, the impact of the direction of DON exposure on epithelial cell behaviour and intestinal
barrier integrity was elucidated.
Methods: A non-transformed intestinal porcine epithelial cell line (IPEC-J2), cultured in membrane inserts, serving as a
polarised in vitro model to determine the effects of deoxynivalenol (DON) on cellular viability and tight junction integrity.
Results: Application of DON in concentrations up to 4000 ng/mL for 24, 48 and 72 hours on the basolateral side of
membrane cultured polarised IPEC-J2 cells resulted in a breakdown of the integrity of cell connections measured by
transepithelial electrical resistance (TEER), as well as a reduced expression of the tight junction proteins ZO-1 and claudin 3.
Epithelial cell number decreased and nuclei size was enlarged after 72 h incubation of 4000 ng/mL DON from basolateral.
Although necrosis or caspase 3 mediated apoptosis was not detectable after basolateral DON application, cell cycle analysis
revealed a significant increase in DNA fragmentation, decrease in G0/G1 phase and slight increase in G2/M phase after
72 hours incubation with DON 2000 ng/mL.
Conclusions: Severity of impact of the mycotoxin deoxynivalenol on the intestinal epithelial barrier is dependent on route
of application. The epithelium appears to be rather resistant towards apical (luminal) DON application whereas the same
toxin dose from basolateral severely undermines barrier integrity.
Citation: Diesing A-K, Nossol C, Da ¨nicke S, Walk N, Post A, et al. (2011) Vulnerability of Polarised Intestinal Porcine Epithelial Cells to Mycotoxin Deoxynivalenol
Depends on the Route of Application. PLoS ONE 6(2): e17472. doi:10.1371/journal.pone.0017472
Editor: Bradley Launikonis, University of Queensland, Australia
Received October 14, 2010; Accepted February 3, 2011; Published February 25, 2011
Copyright:  2011 Diesing et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was financially supported by the European Union in the frame of the project "INTERPLAY" (grant agreement-no. 227549, http://cordis.
europa.eu/fetch?CALLER=FP7_PROJ_EN&ACTION=D&DOC=50&CAT=PROJ&QUERY=012ba9fde3b3:22de:58a7a82c&RCN=92294) and the Deutsche Forschungs-
gemeinschaft (DFG RO 743/3-2, http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jeannette.kluess@med.ovgu.de
Introduction
Deoxynivalenol (DON), a mycotoxin belonging to type B
trichothecenes, is a secondary metabolite of the fungal plant
pathogens Fusarium graminearum and F. culmorum and occurs
predominantly on grains, such as wheat, triticale and maize [1–
4]. It is the most prevalent trichothecene in crop production in
Europe and contaminates common cereal-based diets [5].
Deoxynivalenol is implicated in acute and chronic mycotoxico-
sis in both humans and farm animals [6]. In humans,
deoxynivalenol produces emetic effects and is suspected to induce
more severe diseases such as alimentary toxic aleukia (ATA) or
increased occurrence of oesophageal cancer [7–11]. In animals,
low DON concentrations induce anorexia and alter immune
function, whereas high DON doses induce vomiting, diarrhoea
and malabsorption of nutrients [12,13]. Pigs were identified to be
the most susceptible species [14].
Deoxynivalenol enters the body usually via the oral route and
subsequently encounters the intestinal epithelial cells, representing
the primary target for alimentary intoxication. In vivo and in vitro
experiments report a rapid absorption in the upper gastrointestinal
tract (GIT) [15], a decrease in protein synthesis [16,17] and
various transporters, like GLUT, SGLT-1 and amino acid
transporters [18]. Furthermore, organs belonging to the immune
system (spleen, thymus, bone marrow) appear to be another target
of this agent [19,20].
Pig experiments showed a rapid and nearly complete systemic
absorption (91.5627.4%), with DON appearing already 15
minutes after oral intake in the serum and reaching peak
concentrations already after 1.6560.79 hours [15]. Gastric
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1.8 hours for DON. This rapid disappearance indicates that DON
leaves the stomach most likely with the liquid phase rather than
with the solid (digesta) phase. Furthermore, DON recovery in
various parts of the porcine gastro-intestinal tract (GIT) showed
the upper GIT, i.e. stomach until proximal jejunum, as the most
prominent absorption site. In stomach 88.5% of the initial oral
DON dose was recovered whereas only 1.5% and 10% could be
detected in the upper small intestine and large intestine,
respectively [21]. The rather high amounts of DON in the large
intestine were attributed to the long digesta retention time in this
part of the gut (6–16 hours) and thus to a likely accumulation of
the mycotoxin. However, another explanation could be a re-
absorption mechanism from the systemic side. Interestingly, effects
on intestinal morphology and cell turnover were seen rather for
the mid and distal jejunum than for the upper part (Da ¨nicke et al.,
unpublished data). This leads to the question how this effect could
take place when DON was already absorbed and thus could not
get in direct contact with the apical (luminal) side of the
epithelium? It could be postulated that DON first enters the
blood circulation when absorbed in the upper GIT and then re-
enters the intestinal lumen, passing through the more distal located
intestinal cells from the blood stream via the basolateral side of the
cell. In vitro trials give evidence for the existence of an active DON
transport in the basolateral to apical direction as opposed to simple
diffusion from apical to basolateral in the epithelial cell [22–24].
The functional repertoire of the intestinal cell differs: the apical
side is equipped with the brush border containing a large number
of enzyme and transporter complexes such as lactase, sucrase and
aminopeptidase that facilitate breakdown and absorption of
nutrients from the gut lumen into the blood circulation [25]. On
the basolateral side the transporters for nutrients such as amino
acids or sugars prevail. Consequently, agents intending to enter
the cell might encounter different resistance from the cell
depending on the route of entry and thus differing in its impact
on the cell.
The intestinal epithelium is characterised by tight and adherent
junctions that facilitate cell-cell contact and restrict the para-
cellular transport to small hydrophilic molecules. Transmembrane
and scaffolding proteins such as zonula occludens-1 protein (ZO-1)
and different claudins [26] are responsible for the barrier integrity.
DON was shown to disturb epithelial cell layer integrity measured
by transepithelial electrical resistance in human intestinal CaCo-2
cells [22].
In light of this background it is necessary to investigate the cell
response to the application route of exposure to an agent and thus
help to understand the underlying mechanisms of such a complex
event as mycotoxicosis. Thus we evaluated the effects of DON on
(i) cellular viability and (ii) intestinal barrier integrity, using an in
vitro model of the intestinal porcine epithelial cell line IPEC-J2.
The aim of this study was to evaluate whether DON application
either from the apical or basolateral cell side affects the barrier
function of the intestine more severe.
Materials and Methods
Cell culture conditions
The IPEC-J2 cell line is a non-transformed intestinal porcine
epithelial cell line continuously maintained in cell culture. Cells
were cultured in Dulbecco’s modified eagle medium (DMEM/
Ham’s F-12 [1:1]) supplemented with 5% foetal calf serum (FCS),
1% insulin-transferrin-selenium (ITS), 16 mM HEPES (all PAN-
Biotech, Germany) and 5 ng/mL epidermal growth factor (EGF;
BD Biosciences, Germany) incubated at an atmosphere of 5%
CO2 at 39 uC [27]. Cell cultures were regularly tested by PCR
(VenorH GeM Mycoplasma Detection Kit; Minerva Biolabs,
Germany) and found to be free of mycoplasma contamination.
Cells were routinely seeded at a density of 0.5610
5/mL in plastic
tissue culture flasks (75 cm
2 Nunc, Denmark) and passaged every
3–4 days for a maximum of 20 times (passages 70–90). In our
experiments, IPEC-J2 cells were grown on non-coated, 1 mm pore-
sized culture inserts (6-, 12-, or 24-well ThinCert
TM, Greiner bio-
one, Germany) at a density of 1.0610
5/well for 12 and 24-wells
and 2.0610
5/well for 6-well inserts, respectively, until reaching
confluence. By using culture inserts, cells were grown in a two-
compartment chamber allowing access from both sides, with an
upper compartment subsequently referred to as apical side and a
lower compartment referred to as basolateral side. Culture
medium, containing increasing concentrations (200, 500, 2000
or 4000 ng/mL) of DON (D0156; Sigma-Aldrich, Germany), was
added either in the apical or basolateral compartment for 24, 48
and 72 hours. Assays were performed in singles in at least three
independent experiments.
Preparation of deoxynivalenol (DON)
Purified DON (D0156; Sigma-Aldrich, Germany) was diluted in
absolute ethanol (99.6%; Roth, Germany) to prepare a 0.2 mg/
mL stock solution. Working solutions were prepared in cell culture
medium. A final concentration of 1% ethanol corresponding to the
ethanol concentration of 2000 ng/mL DON solution was tested in
all assays and results were not significantly different from control.
Assays in 24-well format
Transepithelial electrical resistance (TEER). Measure-
ment of TEER was performed using a Millicell electrical resistance
system (Millipore, France). Cells were deemed to be confluent at a
TEER value of $1 kOhm/well, which was routinely after 4 days.
This value derived from previous trials determining the TEER
kinetics of IPEC-J2 cell line in inserts during 21 days (data not shown).
Lactate dehydrogenase activity (LDH). Cellular mem-
brane integrity was assessed by measurement of medium LDH
activity (Cytotoxicity Detection Kit, Roche, Germany). LDH
assay was performed according to manufacturer’s protocol using
100 ml supernatant of the apical side at different time points
(24, 48, 72 h).
Immunohistochemical determination of DNA syn-
thesis. DNA-synthesis was detected by 5’-brome-2’-
deoxyuridine (BrdU; Roche, Germany) incorporation during the
last 6 h of incubation. Membranes were fixed in absolute ethanol
at 4uC for 30 min and in acetone for 3 min, detached, washed in
Tris-buffered saline (TBS, pH 7.6) with 0.05% Tween and
blocked with 1% normal goat serum (NGS, Axxora, Germany)
for 10 min. In general, after each individual step membranes were
washed in TBS/Tween. Membranes were treated with 2 M HCl
at 37 uC for 30 min and neutralised at room temperature in 0.1 M
sodium borate (pH 8.5) twice for 5 min. After 30 min at 4 uCi n
TBS/Tween (0.05%) membranes were incubated with a mouse
monoclonal antibody against BrdU (1:100; BD Pharmingen, USA)
for 30 min. A secondary biotin-labelled goat anti-mouse IgG1
antibody (1:50; Southern biotech, USA) was added for 30 min and
thereafter an ABC-reagent (ABC Elite, Vector Laboratories, USA)
for 60 min at room temperature. Diaminobenzidine solution
(DAB, in 0.1 M PBS, freshly added 0.015% H2O2) was added for
1 min and membranes were subsequently counter-stained with
haematoxylin. The immuno-labelled (brown) and haematoxylin-
stained nuclei (blue) were counted manually.
Cell count. Detached membranes were fixed in absolute
ethanol and acetone. Cells were washed three times with
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with the DNA-intercalating fluorescent dye 4’,6-diamidino-2-
phenylindole (DAPI, Partec, Germany). Fluorescence microscopy
and photographs were performed using an Axiovert 200 M (Zeiss,
Germany) equipped with an AxioCam MRm camera and
corresponding Axiovision software. DAPI-stained nuclei were
counted manually and their respective nucleus area was measured
using Axiovision software.
Assays in 12-well format
Analysis of tight junction structure using immuno-
fluorescence. DON concentration used for immunofo-
fluorescence was 2000 ng/mL. Membranes were detached from
the culture insert and fixed in absolute ethanol and subsequently in
acetone. Cells were washed with phosphate-buffered saline (PBS,
pH 7.4) and blocked for 10 min with 1% NGS. Rabbit anti-ZO-1
or rabbit anti-claudin-3, both diluted at 1:100 (Invitrogen,
Germany), were applied as primary and Alexa fluor 488 goat
anti-rabbit (green), diluted at 1:200 (Invitrogen, Germany) as
secondary antibody. Nuclei were stained with DAPI (Partec,
Germany). Fluorescence microscopy and photographs were done
using an Axiovert 200 M (Zeiss, Germany) with an AxioCam
MRm camera and corresponding Axiovision software.
Assays in 6-well format
Protein isolation and immunoblotting of ZO-1, claudin-3
and caspase 3. DON concentrations used for immunoblotting
comprised 200 and 2000 ng/mL and times were set at 6 and
24 hours for caspase 3. ZO-1 blotting was done for 2000 ng/mL
DON at 24, 48 and 72 hours. Cell homogenate protein was
obtained by 10 min incubation on ice with SDS-gel loading buffer
(1 M Tris base pH 6.8; 1% Glycerol, 10% SDS, 0.1%
Bromophenol blue; freshly added with 0.05% b-mercaptoethanol
and 1% protease inhibitors; Complete, Roche, Germany) and cells
were collected with a cell scraper. Samples were denatured at
95 uC for 5 min and loaded together with a prestained protein
ladder (SM1811; Fermentas, Germany) onto 10% SDS-
polyacrylamide gels. After electrophoresis and semi-dry blotting
onto 0.45 mm nitrocellulose membranes (Whatman, Germany) the
primary rabbit anti-ZO-1 antibody (1:500; Invitrogen, Germany),
rabbit anti-caspase 3 antibody (1:1000, Cell Signaling, Germany)
or rabbit anti-claudin-3 antibody (1:1000; Invitrogen, Germany)
were used in blocking reagent of the corresponding detection kit.
Detection of primary antibody binding on western blot was done
with BM Chemiluminescence Western Blotting Kit mouse/rabbit
(Roche, Germany). After ZO-1, caspase 3 and claudin-3
development, the blots were stripped at 50 uC for 30 min with
stripping buffer (7.58 g Tris base, 20 g SDS, 7 mL ß-
mercaptoethanol, pH 6.8), washed and reprobed with anti-
GAPDH antibody (1:1000, Cell Signaling, Germany). Blots were
analyzed on an Alpha-EaseH FC Imaging System (Alpha Innotech,
Canada).
Cell cycle analysis by flow cytometry. After reaching
confluence cells were synchronised for 24 hours in serum free
media before being exposed to 2000 ng/mL DON. Cells were
trypsinised, pelleted and resuspended in PBS. Ethanol fixation and
propidium iodide (PI; Sigma, Germany) staining proceeding were
performed as previously described [28]. Cells were analysed on a
FACSCalibur flow cytometer using CellQuest ProH software (both
BD Biosciences, Germany).
Statistical analysis
Data were analysed by ANOVA and P values calculated using
Dunnett’s or Tukey’s post hoc test (GraphPad Prism 3.0,
GraphPad Software Inc.). Each value represents a single
measurement of at least three independent experiments. Data
are expressed as means (6SEM). Significant differences between
treated cells and control are indicated by asterisks * p#0.05;
** p#0.01; *** p#0.001.
Results
DON influenced cell number and nucleus area
The cell number, defined by count of DAPI stained nuclei on
membranes, as well as the measured nuclei area, were not
influenced by the application of DON from apical side at any
concentration or time in comparison to the control (DON0). In
contrast, after 24 hours incubation from the basolateral side, we
observed a numerical decrease in number of DAPI-stained nuclei
at 4000 ng/mL DON. However, this decrease reached statistical
significance after 48 hours of DON exposure. After DON
incubation of 72 hours we detected a significantly lower cell count
at 2000 ng/mL and 4000 ng/mL (Fig. 1). Furthermore we
determined the DAPI stained nucleic area. It is noteworthy that
we detected a significant enlargement in nucleus area for 4000 ng/
mL DON from basolateral for 72 hours incubation only (Tab. 1).
DON induced cell proliferation
DNA-synthesis and thus cell proliferation was measured by
BrdU incorporation. We detected a significant relative increase of
proliferation after 48 and 72 h incubation with 2000 ng/mL
DON from basolateral, whereas apical toxin application showed
no effect on DNA synthesis (Fig. 2).
DON did not affect LDH release
Although cell count did change markedly dependent on route of
application of DON we could not observe any alteration in LDH
release at any concentration or incubation time when expressed
relative to control (data not shown).
DON did not induce caspase 3 mediated apoptosis
The protein expression of activated caspase 3, one marker of
cellular apoptosis, was determined using immunoblotting. We did
not see any appearance of the active cleaved caspase 3 protein in
response to DON exposure independent of time, route or
concentration (Fig. 3). The protein expression of the housekeeping
glycolytic protein GAPDH remained stable under all concentra-
tions or times and staurosporine (100 mM) induced detectable
caspase 3 activation.
DON stimulated DNA-fragmentation and G2/M arrest
(Cell cycle analysis)
Analysis of the cell cycle phases by PI-staining using flow
cytometry revealed a marked role of the route of DON exposure
on the toxin effect. Apical toxin exposure did not alter the DNA
content in comparison to control. Cell exposure to DON
2000 ng/mL from basolateral resulted in a significant decrease
in the G0/G1 phase after 48 and 72 hours as well as a significant
increase in preG1 phase after 72 hours (Fig. 4). Although we
observed a numerical increase in cells in G2/M phase after
72 hour DON-treatment this finding was not statistically signifi-
cant.
DON induced breakdown of intestinal barrier integrity
TEER is an indicator for the tight junction integrity of a
confluent epithelial cell layer. In control cells TEER was
essentially constant throughout the experimental period. In our
Deoxynivalenol and Polarised Intestinal Epithelium
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change in TEER even with highest concentrations (4000 ng/mL)
applied. It is noteworthy that DON added to the basolateral side
showed a significant decrease in TEER at 2000 ng/mL and
4000 ng/mL DON already after 24 hours. TEER did not recover
throughout prolonged incubation times (Fig. 5).
DON influenced expression of tight junction proteins
The expression of ZO-1 and claudin-3, proteins of the tight
junction complex between adjacent cells, was investigated using
immunoblotting and immunofluorescence. We found a slight
difference after 48 hours between 2000 ng/mL DON from apical
or basolateral side, the latter resulting in a lower protein
expression. This difference was markedly enhanced after 72 hours
incubation, i.e. the ZO-1 expression in cells treated with 2000 ng/
mL DON from basolateral disappeared completely from the blot
(Fig. 6). In contrast to these findings, the immunofluorescence
staining of ZO-1 did not change the distribution pattern between
Figure 1. Effect of deoxynivalenol (DON) on total cell count of
IPEC- -J2. Cells were grown on inserts and incubated for 24, 48 or
74 hours with DON (0–4000 ng/mL) applied from apical or basolateral
side in complete medium. Data are given as means (6SEM) in triplicates
from three separate experiments. ***p#0.001 vs. DON0.
doi:10.1371/journal.pone.0017472.g001




mL) 24 h 48 h 72 h
ap bl ap bl ap bl
0 139610 134661 3 7 64
200 148617 129651 3 3 641 3 8 616 130671 3 0 66
500 13866 127617 148612 148616 140614 134613
2000 14467 138661 5 0 615 143614 136691 7 0 615
4000 14465 165625 151617 163620 134662 2 5 619***
xCells were incubated for 24, 48 or 74 hours with DON (0–4000 ng/mL) in
complete medium applied from apical (ap) or basolateral (bl) side. Data are
given as means (6SEM) from three separate experiments.
***p#0.001 vs control.
doi:10.1371/journal.pone.0017472.t001
Figure 2. Influence of deoxynivalenol (DON) on proliferation of
IPEC-J2 cells. Cells were grown on inserts, synchronised for 24 hours
in serum free medium and subsequently incubated for 24, 48 or
74 hours with DON (0, 200 or 2000 ng/mL) applied from apical or
basolateral side in complete medium. DNA synthesis was assessed by
BrdU incorporation. Data are given as means (6SEM) from four separate
experiments. ***p#0.001 vs. DON0.
doi:10.1371/journal.pone.0017472.g002
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investigated time point (Fig. 7). ZO-1 was detected as a continuous
lining around each epithelial cell independent of application route.
However, at 72 hours incubation of 2000 ng/mL DON from
basolateral the confluent cell layer was disturbed and thus only cell
islets were distributed on the membrane. Interestingly, DON
showed a more pronounced impact on claudin-3 protein
expressions (Fig. 6) and structure (Fig. 8). Immunoblotting clearly
demonstrated the absence of a claudin-3 signal when DON was
applied from basolateral at each time point. This effect was absent
at apical application. This was confirmed by the immunofluores-
cence staining, where claudin-3 appeared as a continuous lining
around each cell in controls and in cells treated with DON from
apical. Basolateral application elicited a definite disturbance of the
continuous lining, beginning at 24 h and resulting in a complete
disappearance oat 48 and 72 h.
Discussion
One of the most important functions of the intestinal epithelial
cell layer is to form an effective barrier against the uptake of
nutritional antigens, pathogens and toxins [29]. Intestinal
epithelial cells form a polarised layer which effectively separates
the apical (luminal) from the basolateral compartment, i.e. the
lamina propria. Tight junctions between adjacent cells represent an
integral part of this compartmentalisation and any damage to
them leads to an enhanced permeability of the cell layer and a
decreased TEER which can lead to intestinal disorders.
In vitro, cells grown on permeable filter supports are morpho-
logically different from cells grown on non-permeable dishes. They
exhibit a more columnar cell type which is represented in an
increased layer thickness and a lower contact area to the support
(Nossol et al., unpublished data). This morphology is more
comparable to the in vivo situation where the intestinal barrier is a
simple, columnar epithelium [30]. In general, an epithelial cell
layer is characterised by its polarity and the generation of two
compartments, apical and basolateral, thereby creating a physical
barrier. This is facilitated by cell-cell contact and cell-substrate
contact [31]. More importantly, in vivo the intestinal epithelial cell
receives its nutrients from the basolateral as well as from apical
side. Cells cultured on non-permeable supports cannot form the
two compartments and may not be fully polarised. Additionally,
cells have to rearrange their apical domain to accommodate
nutrient supply from the apical side solely [32]. This also implies
that any agent being exposed to the basolateral side of the
epithelial cell also might interfere with the cell’s nutrient supply in
some way. This emphasises the importance of the cell support
chosen for in vitro experiments investigating epithelial or endothe-
lial cell lines.
In our study we observed a significant impact of the mycotoxin
DON on intestinal barrier integrity as well as cell viability in
dependenceon the application route.First,TEER wasdetrimentally
affected already after 24 hours when exposed to 2000 ng/mL DON
from basolateral that persisted after 48 and 72 hours toxin exposure.
The highest DON level (4000 ng/mL) resulted in a TEER-decrease
even below the level of cellular confluence, i.e. 1 kOhm, after
72 hoursexposure.Itisnoteworthythatanyapicalapplicationofthe
toxin did not alter TEER compared to the control. Other studies
[33,34] reported also an impact of DON on TEER using IPEC-1,
CaCo-2 and HT-29 cells, representing frequently used porcine and
human intestinal epithelial cell lines. In these studies the toxin
elicited a significant response from the apical side as opposed to our
data, but a decrease below the level of confluence was only achieved
at the distinctly higher concentrations of 50 and 100 mM( a p p r o x .1 5
and 30 mg/mL) after 72 hours DON exposure. The basolateral
administration was not tested by these authors.
Figure 3. Effect of deoxynivalenol (DON) on apoptosis of IPEC-
J2 cells. Cells were grown on inserts and incubated for 24, 48 or
74 hours with DON (0, 200 or 2000 ng/mL) applied from apical or
basolateral side in complete medium. Protein expression of pro caspase
3 (35 kDa) cleaved caspase 3 (17 kDa) was analysed by immunoblot-
ting. The housekeeping protein GAPDH (37 kDa) was used as loading
control. Staurosporine (100 mM) was used as positive control for cleaved
caspase 3.
doi:10.1371/journal.pone.0017472.g003
Figure 4. Cell cycle analysis of IPEC-J2 cells treated with
deoxynivalenol (DON). Cells were grown on inserts and synchro-
nised for 24 hours in serum free medium and then incubated for 24, 48
or 74 hours with DON (0 or 2000 ng/mL) applied from apical or
basolateral side in complete medium. After staining with propidium
iodide DNA content was analysed by FACS. Data given are means
(6SEM) from five separate experiments. **p#0.01 vs. DON0,
***p#0.001 vs. DON0.
doi:10.1371/journal.pone.0017472.g004
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scaffolding protein ZO-1 and the transmembrane protein
claudin-3, both part of the tight junction complex. They facilitate,
besides others, cell-cell contact and the distinction between apical
and basolateral compartment. Furthermore, ZO-1 as a scaffolding
protein is essential for the spatial organisation of claudins which
are primarily responsible for maintenance of TEER [35].
Immunoblotting of ZO-1 showed a fading signal after 48 hours
that literally became annihilated after 72 hours when cells were
exposed to the toxin from basolateral. Even more pronounced was
the impact on claudin-3, which showed a very faint band after
24 h basolateral toxin exposure and complete absence of signals
after 48 and 72 h basolateral application. Apical toxin exposure
did not change the protein expression as compared to control.
This was also reflected in the immunofluorescence of claudin-3.
Moreover, the intestinal barrier function, as characterised by the
coinciding TEER measurements, was detrimentally affected by the
loss of claudin-3. The protein structure of ZO-1 appeared
surprisingly intact as seen by immunofluorescence, but viewing
the entire cell layer revealed great gaps in the layer, accounting for
cell death and disintegration of the epithelium. This also explains
the drop in protein amount shown by immunoblotting: although
ZO-1 structure between two adjacent cells remained intact, cell
losses increased significantly and thus amount of ZO-1 protein
diminished on a large scale. Other authors also reported no effect
of DON on ZO-1 after 48 h apical incubation despite high doses
(30 mM<9 mg/mL) but a marked deterioration of claudin-3 in the
same study [34]. Total cell count dropped significantly after
48 hours exposure to 4000 ng/mL DON from basolateral and
aggravated during 72 hours toxin exposure. Along with this we
also noticed a significant increase in nucleus area after 72 hours
and 4000 ng/mL DON although not in a dose-dependent way.
Some groups also reported a significant decrease in total cell
numbers in a human K562 erythroleukaemia cell line in response
to DON, although stating statistical significance already at
300 ng/mL DON for a 48 hour incubation [36]. However, these
were immune cells that are known to be more sensitive to DON as
compared to epithelial cell lines [37]. Interestingly, we could
neither detect necrotic cell death as measured by LDH assay nor
caspase 3 mediated apoptosis despite the drastic decrease in total
cell count. This lack of LDH release in DON-treated intestinal
epithelial cells (CaCo-2, IPEC-1) despite a marked decrease in
TEER and cell reduction capacity (MTT assay) was earlier
reported [22,34]. In immune cells a significant increase in
apoptotic cell death after 24 hours DON exposure ($10 mg/mL)
was given, but no effect on necrotic cell death [37]. The same
study showed no impact on these parameters on the epithelial cell
lines tested, BHK21 (kidney cells) and MH-22a (liver cells).
Contradictory, some authors found a marked LDH release
following DON exposure, but at rather high concentrations of
100 mM( <30 mg/mL) for 48 hours (CaCo-2) and 30 mM( <9 mg/
mL) for 24 hours (HT-29-D4), respectively [23,33].
One possible explanation for the lack of LDH release seen in our
study could be that cells undergo anoikis rather than apoptosis.
Anoikis represents a special form of programmed cell death where
anchorage-dependentcells,suchasepithelialcells,detachfromtheir
surrounding cell layer and matrix by severing bonds mediated by
hemidesmosomes or integrins. This way the cell membrane of the
dying cell is still intact and would not release LDH [38,39].
Using flow cytometry we investigated the effect of mycotoxin
exposure route on cell cycle. We observed a significant decrease in
G0/G1 already after 48 h and an increase in preG1 phase after
Figure 5. Impact of deoxynivalenol (DON) on transepithelial
electrical resistance (TEER) in polarised IPEC-J2 layers. Cells
were grown on inserts and incubated for 24, 48 or 72 hours with DON
(0–4000 ng/mL) applied from apical or basolateral side in complete
medium. TEER values are expressed in kOhms per insert (0.3 cm
2) with
1 kOhm being the level of confluence. Data are given as means (6SEM)
from at least 14 separate experiments. ***p#0.001 vs. DON0.
doi:10.1371/journal.pone.0017472.g005
Figure 6. Western blot of tight junction proteins ZO-1 and
claudin-3 in IPEC-J2 cells treated with deoxynivalenol (DON).
Cells were grown on inserts and incubated for 24, 48 or 74 hours with
DON (0 or 2000 ng/mL) applied from apical or basolateral side in
complete medium. ZO-1 (225 kDa) and claudin-3 (22 kDa) expression
was analysed by immunoblotting. The housekeeping protein GAPDH
(37 kDa) was used as loading control.
doi:10.1371/journal.pone.0017472.g006
Deoxynivalenol and Polarised Intestinal Epithelium
PLoS ONE | www.plosone.org 6 February 2011 | Volume 6 | Issue 2 | e1747272 hours basolateral DON application. Other groups reported a
similar impact of the mycotoxin on cell cycle, in particular on cell
cycle arrest in epithelial cells [40,41]. The increase in preG1 phase,
representing subdiploid, apoptotic cells [42], was also reported in
IPEC-1 cells [43]. This increase points towards the apoptotic
pathway rather than a cell cycle arrest. Caspase 3, one of the effector
proteins of apoptosis, was not activated during the investigated time
frame in our study, being somewhat contradictory to the data on cell
cycle. However, caspase 3 was activated after 6, 8 and 12 hours of
DON exposure in IPEC-1 or HT-29 cells grown on non-permeable
plastic dishes [43,44]. Probably either the signal for caspase 3
activationwastooweak orthe pathway ofapoptosiswasactivatedin a
caspase 3 independent manner in cells growing on permeable inserts.
Although caspase-dependent apoptosis seemsto be a common type of
cell death it became apparent that cells could also die when caspase
function is blocked. This type of cell death is termed caspase-
independent cell death (CICD) that occurs in response to
mitochondrial outer membrane permeabilisation and disruption of
mitochondrial morphology. In this process death receptor activation
leads to so-called necroptosis (i.e. cell death) through the upregulation
of phospholipase A2 (PLA2) activity that in turn increases oxidative
stress or by effecting autophagy [45]. However, the question of
caspase-independent cell death was not further pursued in our trial.
DNA synthesis was determined on single cell level using the
thymidine-analogue BrdU. Although we observed a significant
decrease in total cell count after 48 and 72 h of basolateral DON
application, nearly all of those remaining cells were proliferating,
possibly attempting to close the gaps in the IPEC-J2 layer. This
resulted in a significant relative increase of proliferation compared to
control.Sofarwe can not decide whether this increased BrdU uptake
is as primary DON effect or a secondary effect due to the cell death
related gaps in the cell layer. Apical DON application elicited no
response in DNA synthesis. This surprising resultis in contrast to data
reported in literature [46]. However, in vitro studies used predomi-
nantly BrdU-ELISA that provides information only for the entire cell
population. Furthermore, relationships between the actual cell
number and those of proliferating cells are rarely given and cells
are cultivated on impermeablesupports.One study used proliferating
cell nuclear antigen (PCNA) as a single cell marker for proliferation,
however this marker decreased in response to DON [47].
One striking aspect of former studies reporting on epithelial cells
is that the cell layer was exposed to DON from the apical side in
most cases. Most likely this originated from the idea that this apical
exposure is the result of the oral intake of this mycotoxin whereby
it will encounter the enterocytes from the luminal side.
Furthermore, most assays, with the exception of TEER measure-
ments were conducted on cells grown on non-permeable plastic or
glass dishes. In our study we did see a surprising resilience of
intestinal epithelial cells against DON when added to the apical
side with virtually no effect in the applied assays. In contrast the
basolateral application of the same mycotoxin concentration
elicited a clear, dose-dependent response with impairment of the
epithelial barrier integrity and an increase in apoptotic cell death,
starting with quite lower DON concentrations than applied in
other studies. As all experimental conditions were the same with
the exception of route of toxin application we can assume that the
cell support and the resulting changes in cell layer formation
played a crucial role.
Figure 7. Cellular distribution of the tight junction protein ZO-1 in IPEC-J2 monolayers treated with deoxynivalenol (DON). Cells
were grown on inserts and incubated for 24, 48 or 74 hours either without DON (upper panel) or with 2000 ng/mL DON applied from apical (middle
panel) or basolateral side (lower panel) in complete medium. Monolayers were stained for the tight junction associated protein ZO-1 and nuclei
stained with DAPI, then detected by immunofluorescence microscopy. All micrographs were taken under identical exposure time and in the centre of
each membrane. Micrographs are representative for 3 separate experiments with similar results. Scale bar = 50 mm.
doi:10.1371/journal.pone.0017472.g007
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more sensitive to agents from the basolateral side as compared to
apical exposure [48]. Interleukin-8 was significantly higher
secreted by CaCo-2 cells grown on filters and exposed to E. coli
from basolateral. This interleukin secretion was even amplified by
DON, although this was only applied apically. The author’s
explanation for this difference in sensitivity was the existence of
toll-like receptor 5 (TLR-5) which is present on the basolateral
side of the epithelial cell and in charge for the detection of
bacterial flagellin [49]. Another study reported about the
difference in impact of adenosine administered either from apical
or basolateral to T84 colonic cells in vitro [50]. Ussing chamber
experiments revealed a more potent effect of adenosine from
basolateral on short-circuit current as well as on cellular cAMP.
The authors explained these differences with distinct receptor
proteins and density as well as different linkage to post-receptor
signalling mechanisms. In vivo, a rapid absorption of DON in the
upper small intestine of growing pigs, confined to the duodenum
and the proximal jejunum, was found. Indicative for this rapid
absorption were the fast serum peak concentrations
(1.65 h60.79 h) and the extremely low recovery of DON (1.5%
of initial dose) after oral ingestion of the mycotoxin [15,21].
Moreover, only 2.5% of the oral DON dose was excreted via
faeces whereas the majority was excreted via the urinary tract. An
efficient urinary excretion indicates a high gastro-intestinal
absorption while a high faecal absorption might be due to an
efficient biliary excretion or a lack of systemic absorption. As
faecal elimination of DON in pigs was very low and systemic
absorption very high we can deduce that a hepatic first pass effect
of DON is negligible [15]. Although the toxin was in direct
contact with the apical cell surface the authors could not see any
alterations in terms of morphology and proliferation of epithelial
cells. However, they reported marked effects in the mid-jejunum
and ileum such as an increase in crypt depth and altered protein
turnover, which in all likelihood could not have come in contact
with substantial luminal amounts of DON. On one hand these in
vivo data support our own results on the resilience of the apical
cell surface towards DON. On the other hand it poses the
question on how these epithelial changes could take place so
distant from the actual site of absorption. One explanation would
be that the mycotoxin enters the jejunal and ileal intestinal cells
from the basolateral, i.e. blood stream side, after absorption in
more proximal parts.
Inconclusion,wecould demonstratethattheresponseofthenon-
transformed, non-cancerous epithelial cell line IPEC-J2 to the
mycotoxin deoxynivalenol differed dramatically depending on the
route of toxin exposure. In particular, the basolateral domain of the
intestinal barrier was significantly more vulnerable as compared to
their apical counterpart. This result suggests a potential mechanism
for the in vivo changes in intestinal barrier distal from the actual site
of high apical DON exposure as discussed above. Moreover, this
emphasises the importance of establishing a truly polarised cell layer
when addressing physiological and pathophysiological questions of
the intestinal epithelium in vitro.
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